SCHEMBL2236276

SCHEMBL2236276

N#Cc1cnccc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL166316 0.82
SCHEMBL30166533 0.82
SCHEMBL14393839 0.79
SCHEMBL20043 0.78 HTT (0.50)
SCHEMBL29546988 0.78 HTT (0.50)
SCHEMBL1043688 0.77
SCHEMBL31133690 0.76 HTT (0.48)
SCHEMBL28162273 0.75 CYP1A2 (0.45)
SCHEMBL4135652 0.74 GAA (0.43)
SCHEMBL21722106 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484865-B1 SOMATOSTATIN MODULATORS AND USES THEREOF CRINETICS PHARMACEUTICALS INC (US) 2022-09-14 EP claimed
EP-2529388-B1 FRAGMENTATION REAGENTS FOR MASS SPECTROMETRY MICROMASS LTD (GB) 2019-10-23 EP claimed
US-20130122599-A1 Fragmentation Reagents For Mass Spectrometry MICROMASS UK LIMITED (GB) 2013-05-16 US claimed
EP-2529388-A1 FRAGMENTATION REAGENTS FOR MASS SPECTROMETRY Micromass UK Limited (GB) 2012-12-05 EP claimed
WO-2011092515-A1 FRAGMENTATION REAGENTS FOR MASS SPECTROMETRY MICROMASS UK LIMITED (GB) 2011-08-04 WO claimed
EP-1222188-A1 NOVEL IMIDAZOPYRIDINE CARBONITRILE COMPOUNDS AstraZeneca AB (SE) 2002-07-17 EP claimed
WO-2001025237-A1 NOVEL IMIDAZOPYRIDINE CARBONITRILE COMPOUNDS ASTRAZENECA AB (SE) 2001-04-12 WO claimed
US-5480995-A Process for the preparation of 6-amino-nicotinonitriles BAYER AKTIENGESELLSCHAFT (DE) 1996-01-02 US claimed
EP-0057827-B1 PROCESS FOR THE PREPARATION OF 2-AMINOPYRIDINE DERIVATIVES BASF Aktiengesellschaft (DE) 1986-08-13 EP claimed
US-4395555-A Preparation of 2-aminopyridine derivatives BASF AKTIENGESELLSCHAFT (DE) 1983-07-26 US claimed
EP-4719394-A2 INHIBITORS OF TYK2 Atomwise Inc. (US) 2026-04-08 EP disclosed
US-20260048051-A1 TREATMENT OF INFLAMMATORY BOWEL DISEASE ATOMWISE INC (US) 2026-02-19 US disclosed
US-12358904-B2 Inhibitors of TYK2 Atomwise Inc. (US) 2025-07-15 US disclosed
US-20240425484-A1 INHIBITORS OF TYK2 Atomwise Inc. 2024-12-26 US disclosed
US-20240417396-A1 INHIBITORS OF TYK2 Atomwise Inc. 2024-12-19 US disclosed
US-4567186-A 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof and intermediates therefor STERLING DRUG INC. (US) 1986-01-28 US disclosed
US-4410465-A Preparation of butadiene dinitriles BASF AKTIENGESELLSCHAFT (DE) 1983-10-18 US disclosed
US-4395555-A Preparation of 2-aminopyridine derivatives BASF AKTIENGESELLSCHAFT (DE) 1983-07-26 US disclosed
US-4395555-A Preparation of 2-aminopyridine derivatives BASF AKTIENGESELLSCHAFT (DE) 1983-07-26 US disclosed
EP-0046446-A1 Polyazaheterocyclic compounds, process for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1982-02-24 EP disclosed